ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LARISA MERAS M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,376Medicare Part D Prescriptions Filled, Including Refills

Rank: 253 out of 5176

$721K Total Retail Price of All Prescriptions

Rank: 577 out of 5176

392 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 13,657 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LEVOTHYROXINE SODIUM 748 721 1 4
DONEPEZIL HCL 466 461 2 28
OMEPRAZOLE 465 427 3 3
FUROSEMIDE 433 414 4 8
AMLODIPINE BESYLATE 385 382 5 2
CITALOPRAM HBR 376 367 6 31
WARFARIN SODIUM 342 342 7 13
NAMENDA 341 332 8 47
METOPROLOL TARTRATE 339 334 9 6
MIRTAZAPINE 313 312 10 45
HYDROCODONE-ACETAMINOPHEN 244 236 S3 11 27
RANITIDINE HCL 232 221 12 36
POLYETHYLENE GLYCOL 3350 221 209 13 74
GABAPENTIN 219 209 14 21
LISINOPRIL 209 192 15 5
QUETIAPINE FUMARATE 206 171 16 75
DIVALPROEX SODIUM 195 195 17 104
METFORMIN HCL 173 147 18 7
LOVASTATIN 159 159 19 46
POTASSIUM CHLORIDE 155 141 20 34
TRAZODONE HCL 151 151 21 71
METOPROLOL SUCCINATE 148 130 22 11
CARBIDOPA-LEVODOPA 146 146 23 98
CARVEDILOL 145 126 24 24
RISPERIDONE 139 139 25 78
CEPHALEXIN 135 134 26 189
CLOPIDOGREL 135 127 26 26
SERTRALINE HCL 125 116 28 30
ALLOPURINOL 122 116 29 41
ATORVASTATIN CALCIUM 121 114 30 9
ATENOLOL 101 94 31 12
NOVOLIN N 99 88 32 304
ISOSORBIDE MONONITRATE ER 98 98 33 44
TAMSULOSIN HCL 98 87 33 20
CLONIDINE HCL 97 86 35 79
PLAVIX 97 92 35 29
PRAVASTATIN SODIUM 97 91 35 23
FAMOTIDINE 94 92 38 58
NYSTOP 92 87 39 283
PREDNISONE 89 87 40 52
LIDODERM 87 86 41 59
HYDRALAZINE HCL 86 84 42 73
SIMVASTATIN 86 57 42 1
DIGOXIN 82 74 44 56
IPRATROPIUM-ALBUTEROL 77 74 45 138
NITROGLYCERIN PATCH 76 76 46 149
MELOXICAM 74 74 47 53
HYDROCORTISONE 71 64 48 265
SEROQUEL 70 63 49 166
DIOVAN 69 62 50 19
IBUPROFEN 69 67 50 72
PANTOPRAZOLE SODIUM 68 68 52 61
CIPROFLOXACIN HCL 66 66 53 84
NYSTATIN-TRIAMCINOLONE 64 60 54 142
ESCITALOPRAM OXALATE 64 64 54 89
HYDROXYZINE HCL 64 64 R 54 213
ENOXAPARIN SODIUM 63 63 57 305
ALENDRONATE SODIUM 63 63 57 18
CYMBALTA 62 62 59 90
BUMETANIDE 60 60 60 209
DILTIAZEM 24HR CD 59 59 61 119
ENALAPRIL MALEATE 59 49 61 22
CRESTOR 58 53 63 15
TRAMADOL HCL 57 47 64 40
OXYBUTYNIN CHLORIDE 56 48 65 227
METHADONE HCL 55 55 S2 66 310
TRIAMTERENE-HCTZ 55 55 66 86
TIMOLOL MALEATE 55 55 66 318
CEFPODOXIME PROXETIL 54 51 69 399
SPIRONOLACTONE 54 54 69 88
SANTYL 54 52 69 124
PAROXETINE HCL 54 54 69 93
BUSPIRONE HCL 53 50 73 183
ADVAIR DISKUS 53 53 73 32
AZITHROMYCIN 51 50 75 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.